Erlotinib tablet used in the treatment of non-small cell lung cancer(NSCLC) and pancreatic cancer. The Erlotinib tablet is used in the treatment of non-small cell lung cancer when administered with chemotherapy. This medication is specifically used in case of epidermal growth factor receptor (EGFR). The Erlotinib tablets is effective against or without EGFR but Highly Effective against when EGFR is present.
Side Effects: Some of the less common side effects experienced by the patients receiving erlotinib medication:
Below mentioned are few side effects of erlotinib a lung cancer medication:
Some of the serious adverse reaction of Erlotinib 150 mg tablet is:
0 Comments
Leave a Reply. |